[ad_1]
he Department of Health The new formulation of the vaccine was confirmed on Tuesday. Coronavirus disease Approved U.S. Food and Drug Administration (FDA).
The vaccine is designed to provide more effective protection against the latest variants of the virus. Virus SARS-CoV-2,include omicron variant of strain KP.2.
As noted in the press release, the vaccine contains a monovalent component, meaning it specifically targets a single variant of the virus, in this case, Low KP.2. The new formula is Messenger RNA Clinical studies have shown its ability to induce a strong and durable immune response, suggesting sustained protection against disease.
this Dr. Iris Cardona, Chief Medical Officer Explaining that “new vaccine formulations remain an important tool in the global COVID-19 control strategy, in conjunction with other public health measures.”
He also stressed that “the FDA’s approval emphasizes adherence to the highest standards of safety and effectiveness, which is critical for its use in the general population.”
Available vaccines, e.g. Community yes vaccineapproved for people 12 years and older, with a version for children six (6) months to 11 years, was developed by Moderna and Pfizer-BioNTech. The vaccine is particularly recommended for people with compromised immune systems, older adults, and those with chronic medical conditions. The Centers for Disease Control and Prevention (CDC) recommends its use in all people.
he Dr. Carlos Melardo Lopez, The Health Minister also highlighted the context of this new vaccine rollout, “We know that the virus continues to evolve, and our response must be equally dynamic. While we have learned how to coexist with COVID-19, it is important to remember that the threat has not gone away.”
So far this year, 94.99% of deaths occurred in people over 60 years oldIn addition, there were 2 deaths in the 0 to 9 age group, 1 death in the 10 to 19 age group, and 1 death in the 20 to 29 age group.
To schedule an at-home vaccination for a bedridden person or to find the nearest vaccination center, you can call 787-522-3985 between 8:00 a.m. and 4:00 p.m., Monday through Friday.
[ad_2]
Source link
